FDA Extends PDUFA Date For Valneva's Chikungunya Virus Vaccine Candidate
14/8 07:26
(RTTNews) - Valneva SE (VLA) said Monday that the U.S. Food and Drug Administration has extended the Prescription Drug User Fee Act or PDUFA action date for the Biologics License Application or BLA for the company's chikungunya virus vaccine candidate, VLA1553, from the previousl...